Technology News and Research

RSS

Etubics enters Phase I trials for next generation vector vaccines

Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.

29 Jul 2010

Cerner second-quarter revenue increases 13% to $456.0 million

Cerner Corporation today announced results for the 2010 second quarter that ended July 3, 2010, delivering strong levels of bookings, revenue, earnings and cash flow.

29 Jul 2010

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ(TM) Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.

29 Jul 2010

Anti-fraud efforts backed by AARP; Seniors cautioned about rebate cons

AARP on Tuesday "threw its influence" behind a number of plans to reduce Medicare fraud, including the bipartisan Medicare Fraud Enforcement and Prevention Act, which would increase penalties on nabbed fraudsters and supply more claims data to enforcers, The Hill reports. Separate legislation, "the Fighting Fraud with Innovative Technology Act, would bolster Medicare's claims screening process before payments are sent out" (Lillis, 7/27).

29 Jul 2010

HemoBioTech receives patent for HemoTech treatment of acute blood loss

HemoBioTech announced today the issuance of a new patent US 7,759,306 B2, Methods of Treating Acute Blood Loss. HemoBioTech has an exclusive worldwide license from Texas Tech University to commercialize the technology. The new patent continues to May 16, 2026. The major advance in HemoTech is the presence of Adenosine which has anti-inflammatory activity.

29 Jul 2010

CompuMed signs agreement with Lincoln High School Learning Centers

CompuMed, Inc., a telemedicine and medical informatics company, has entered into an agreement with the San Diego Unified School District's Lincoln High School Learning Centers to provide CompuMed's CardioGramKids electrocardiogram telemedicine technologies and services to the four schools that comprise the Lincoln High Learning Centers: the Lincoln High Schools of Public Safety, Science & Engineering, Arts and Social Justice.

28 Jul 2010

Health Grades reports net income of $3.2 million for second-quarter 2010

Health Grades, Inc., the leading independent healthcare ratings company, today reported financial results for the second quarter ended June 30, 2010.

28 Jul 2010

Clinical Pharmacokinetics Research Laboratory deploys AB SCIEX mass spectrometry technology

AB SCIEX, a global leader in life science analytical technologies, today announced that the Clinical Pharmacokinetics Research Laboratory at the University of Rhode Island's College of Pharmacy is using AB SCIEX mass spectrometry technology to develop a novel test that would enable clinical researchers to use saliva to monitor immunosuppressant drugs commonly administered to make organ transplants successful.

28 Jul 2010

Mastech second-quarter revenues decrease to $16.9 million

Mastech Holdings, Inc., a national provider of Information Technology and Specialized Healthcare staffing services, announced today its financial results for the second quarter ended June 30, 2010.

28 Jul 2010

Redpoint Bio issued patent that covers high-throughput screening technology

Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."

28 Jul 2010

Water Pik launches advertising campaign to introduce consumers to new Waterpik Water Flosser

Water Pik, Inc., a leading developer and manufacturer of innovative personal healthcare products, today announced the launch of the "Say No To String" advertising campaign to introduce consumers to the new Waterpik Water Flosser and to promote it as an easier and more effective alternative to traditional string floss.

28 Jul 2010

Vitro Diagnostics, Mokshagundam Biotechnologies enter contract to develop stem cell-derived food

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it has entered into a contract with Mokshagundam Biotechnologies, a private research organization established to develop alternative meat sources, to develop cell culture medium for use in exploration of alternative food sources derived from stem cells.

28 Jul 2010

American Red Cross explores new ways to utilize mGive platform and services

mGive and the American Red Cross have extended their ability to use mobile technologies to engage supporters using the mobile channel. mGive, a pioneer and leader in powering mobile donations for nonprofit organizations, and the Red Cross previously cooperated to raise the largest amount of mobile donations ever contributed following the Haiti earthquake, involving more supporters compared to any previous mobile fundraising campaign.

28 Jul 2010

EyeHealth Northwest to deploy NextGen Ambulatory EHR and Practice Management solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced it has executed an agreement with EyeHealth Northwest to deploy NextGen® Ambulatory EHR and NextGen® Practice Management across its 11 offices, 11 optical shops and two surgery centers in Oregon.

28 Jul 2010

Aphios awarded US patent for compositions, methods for treating diseases involving 5-α reductase enzyme

Aphios® Corporation today announced that it was awarded United States Patent No. 7,744,935 B2 for "Compositions and Methods for Inhibiting 5-α Reductase," granted June 29, 2010. This invention is related to compositions and methods for treating diseases involving the 5-alpha (α) reductase enzyme.

28 Jul 2010

Experts to discuss treatment options for wounded warriors at USU-HJF Military Medicine Symposium

The USU-HJF Military Medicine Symposium will gather prominent civilian and military researchers and clinicians from across the United States to discuss current research and identify opportunities to collaborate and share information that could speed treatments to wounded warriors. The symposium also will bring together a broad spectrum of participants from military health leadership, federal agencies and private research institutions to philanthropists and charitable foundations, representatives of industry, and policymakers.

28 Jul 2010

Experts outline five principles to reduce incidence of diagnostic errors

Errors in diagnosis place a heavy financial burden on an already costly health care system and can be devastating for affected patients. Strengthening certain aspects of a new and evolving model of comprehensive and coordinated primary care could potentially address this highly relevant, but underemphasized safety concern, say Mark Graber, M.D., of Stony Brook University Medical Center, and Hardeep Singh, M.D., M.P.H., of Baylor College of Medicine, in a commentary published in the July 28 issue of the Journal of the American Medical Association.

28 Jul 2010

Positive results from study with Genome Sequencer FLX System for HIV drug-resistant mutation detection

454 Life Sciences, a Roche Company, has announced promising new results from a multi-site collaborative research study which used the company's Genome Sequencer FLX System to perform HIV drug-resistant mutation detection.

28 Jul 2010

Astellas extends non-exclusive license agreement with Regeneron for VelocImmune technology

Regeneron Pharmaceuticals, Inc. and Astellas Pharma Inc. announced that Astellas has extended through 2023 the non-exclusive license agreement that allows Astellas to utilize Regeneron's VelocImmune® technology in its internal research programs to discover fully human monoclonal antibody product candidates.

28 Jul 2010

Roche to present diagnostics testing solutions at 2010 Clinical Lab Expo

Roche is featuring a diverse portfolio of diagnostics testing solutions for healthcare professionals in booth #2808 at the AACC/CSCC 2010 Clinical Lab Expo here, July 27-29 – and it's giving them a unique way to see firsthand where their own "dream lab" might take them.

From Roche Sequencing and Life Science 28 Jul 2010

Technology News and Research

Etubics enters Phase I trials for next generation vector vaccines

Cerner second-quarter revenue increases 13% to $456.0 million

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

Anti-fraud efforts backed by AARP; Seniors cautioned about rebate cons

HemoBioTech receives patent for HemoTech treatment of acute blood loss

CompuMed signs agreement with Lincoln High School Learning Centers

Health Grades reports net income of $3.2 million for second-quarter 2010

Clinical Pharmacokinetics Research Laboratory deploys AB SCIEX mass spectrometry technology

Mastech second-quarter revenues decrease to $16.9 million

Redpoint Bio issued patent that covers high-throughput screening technology

Water Pik launches advertising campaign to introduce consumers to new Waterpik Water Flosser

Vitro Diagnostics, Mokshagundam Biotechnologies enter contract to develop stem cell-derived food

American Red Cross explores new ways to utilize mGive platform and services

EyeHealth Northwest to deploy NextGen Ambulatory EHR and Practice Management solutions

Aphios awarded US patent for compositions, methods for treating diseases involving 5-α reductase enzyme

Experts to discuss treatment options for wounded warriors at USU-HJF Military Medicine Symposium

Experts outline five principles to reduce incidence of diagnostic errors

Positive results from study with Genome Sequencer FLX System for HIV drug-resistant mutation detection

Astellas extends non-exclusive license agreement with Regeneron for VelocImmune technology

Roche to present diagnostics testing solutions at 2010 Clinical Lab Expo

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News